Influenza Vaccines
Research results from University of Melbourne, Murdoch Children's Research Institute update understanding of influenza vaccines
Published in Vaccine Weekly, September 17th, 2008
A report, 'Phase I and II randomised trials of the safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in healthy adults,' is newly published data in Vaccine. According to recent research published in the journal Vaccine, "The primary objective was to evaluate the safety and immunogenicity of a prototype inactivated, split-virus H5N1 (avian influenza A) vaccine. A secondary objective was to assess the cross-reactivity of immune responses to two variant clade 2 H5N1 strains."
"In two randomised, dose comparison, parallel assignment, multicentre trials conducted in Australia, healthy adult volunteers...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2008-09-17)
More Articles from Vaccine Weekly
- American Thoracic Society
Flu shot does not reduce risk of death - Canadian Medical Association Journal
Higher anaphylaxis rates after HPV vaccination: CMAJ study - Bird Flu
Data on bird flu reported by T. Ogata and co-researchers - DNA Vaccines
Studies from Shandong University, Medical Department yield new data on DNA vaccines - Every Child By Two
Immunization Rates Remain Strong - Hookworm Disease
Research results from George Washington University update knowledge of hookworm disease - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
